PIM2 and prostate carcinoma: This latter hypothesis is consistent with the results of Dai et al. [13], reporting a shift from a predominant nuclear expression of PIM-2 in normal prostate epithelium cells, to an increased cytoplasmic expression in prostate cancer cells (PCa).